Ting-Wei Chang

Title: Innovations of Ting-Wei Chang in Thrombosis Treatment.

Introduction

Ting-Wei Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of pathological blood clots. His innovative work has the potential to improve patient outcomes in thrombosis management.

Latest Patents

Ting-Wei Chang holds a patent for a polypeptide designed for treating pathological blood clots. This patent includes a polypeptide that comprises an anti-fibrin antibody and a serine protease moiety of human tissue plasminogen activator. The methods disclosed in this patent provide a novel approach for treating thrombosis in individuals who require such intervention.

Career Highlights

Chang is currently associated with Immunwork Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions for medical challenges, particularly in the area of thrombosis.

Collaborations

Ting-Wei Chang collaborates with esteemed colleagues, including Tse-Wen Chang and Hsing-Mao Chu. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Ting-Wei Chang's contributions to the treatment of thrombosis through his innovative polypeptide patent highlight his role as a significant inventor in the medical field. His work at Immunwork Inc. and collaborations with fellow researchers further emphasize his commitment to improving healthcare solutions.